Research
The goal of “KIRR Real: Real-World Lab for Legally Compliant AI and Robotics,” a joint initiative by Fraunhofer IPA and ARENA2036, was to support companies in Baden-Württemberg in implementing the EU AI Act and the EU Machinery Directive, which will take effect in 2027. The results of the collaboration with 15 companies have now been […]
read more
Drug development: New NMI framework reduces risk of costly failure
How can the risk of failure in the development of drug compounds be reduced? In a recent paper, researchers at the NMI present a newly developed framework that makes the development of drug compounds from so-called single-domain antibodies (sdAb) safer and more reliable. Until now, drug development has generally proceeded as follows: one starts with […]
read more
How cancer immunotherapies affect the heart
The Hector Foundation is providing €1.3 million in funding for an interdisciplinary research project investigating the cardiological side effects of checkpoint inhibitors. The consortium, with partners at Heidelberg University’s Medical Faculty, the German Cancer Research Center, the Max Delbrück Center in Berlin, and the University Medical Center Schleswig-Holstein in Kiel, is investigating why these cancer […]
read more
Early detection contributes to declining breast cancer mortality rates in Europe
The introduction of mammography screening programs in Europe has significantly changed breast cancer diagnoses, accompanied by a decline in breast cancer mortality rates. This is shown by one of the most comprehensive analyses of population-based data on breast cancer in 21 European countries to date, led by the German Cancer Research Center (DKFZ). The most […]
read more
Drug development: New NMI framework reduces risk of costly failure
How can the risk of failure in the development of drug compounds be reduced? In a recent paper, researchers at the NMI present a newly developed framework that makes the development of drug compounds from so-called single-domain antibodies (sdAb) safer and more reliable. Until now, drug development has generally proceeded as follows: one starts with […]
read more
A human mini-bladder shows the culprit of recurrent infections
Researchers at EPFL, Heidelberg University and Roche have built a human mini-bladder to show how urine composition weakens bladder tissue, helping infections recur even after antibiotics. The bladder is not just a static storage bag; its lining stretches, relaxes, and stays in constant contact with urine whose composition changes with hydration, diet, and disease. Urine […]
read more
Hardware for humanoid robots: New perspectives for industrial value creation in Europe
Together with the management consultancy P3, Fraunhofer IPA has investigated how component manufacturers could benefit from producing hardware components for humanoid robots. The results are available free of charge in the white paper “The Humanoid Hardware Value Chain: Can the European Manufacturing Industry Capitalize on the Humanoid Momentum?” Humanoid robots are currently developing at a […]
read more
A “Plug” for Light-Controlled Chips
How Heidelberg scientists address photonic processors Addressing a photonic microchip that is driven by light just as easily as electronic components via a “plug”, rather than by expending extensive experimental effort: this vision has now been realized by physicists and chemists at Heidelberg University. Their development could serve as the basis for fast and cost-effective […]
read more
Thermogenetics: How Proteins Are Controllable by Heat
Modular design strategy makes it possible to precisely control cellular functions through minimal temperature changes Protein activity can be precisely regulated via subtle changes in temperature using heat-sensitive switches. Underlying this capability is a novel modular design strategy developed by researchers at the Institute of Pharmacy and Molecular Biotechnology of Heidelberg University. The strategy allows […]
read more
